Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity

Cell Host and Microbe

Volumn 19, Issue 4, 2016, Pages 504-514

  Krapp, Christian ^a   Hotter, Dominik ^a   Gawanbacht, Ali ^a   McLaren, Paul J ^b   Kluge, Silvia F ^a   Stürzel, Christina M ^a   Mack, Katharina ^a   Reith, Elisabeth ^a   Engelhart, Susanne ^a   Ciuffi, Angela ^c   Hornung, Veit ^d   Sauter, Daniel ^a   Telenti, Amalio ^e   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF MUNICH   (Germany)

^e J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE PHOSPHATE 5; GUANOSINE TRIPHOSPHATASE; INTERFERON; UNCLASSIFIED DRUG; GBP5 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRAL PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RETROVIRIDAE; START CODON; TARGET CELL; VIRION; VIRUS INFECTIVITY; VIRUS STRAIN; ENZYMOLOGY; GENETICS; GOLGI COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY;

GOLGI APPARATUS; GTP-BINDING PROTEINS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; INTERFERONS; MACROPHAGES; PROTEIN TRANSPORT; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84961221171     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2016.02.019     Document Type: Article

References (51)

1. S.L. Anderson, J.M. Carton, J. Lou, L. Xing, and B.Y. Rubin Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus Virology 256 1999 8 14
2. I. Bartha, P.J. McLaren, A. Ciuffi, J. Fellay, and A. Telenti GuavaH: a compendium of host genomic data in HIV biology and disease Retrovirology 11 2014 6
3. S.M. Bol, Y. van Remmerden, J.G. Sietzema, N.A. Kootstra, H. Schuitemaker, and A.B. van't Wout Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages Virology 390 2009 205 211
4. N. Britzen-Laurent, M. Bauer, V. Berton, N. Fischer, A. Syguda, S. Reipschläger, E. Naschberger, C. Herrmann, and M. Stürzl Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner PLoS ONE 5 2010 e14246
5. T.H. Burdo, A. Lackner, and K.C. Williams Monocyte/macrophages and their role in HIV neuropathogenesis Immunol. Rev. 254 2013 102 113
6. M. Cavrois, C. De Noronha, and W.C. Greene A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes Nat. Biotechnol. 20 2002 1151 1154
7. M.A. Chattergoon, R. Latanich, J. Quinn, M.E. Winter, R.W. Buckheit 3rd, J.N. Blankson, D. Pardoll, and A.L. Cox HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon PLoS Pathog. 10 2014 e1004082
8. A. Ciuffi, G. Bleiber, M. Muñoz, R. Martinez, C. Loeuillet, M. Rehr, M. Fischer, H.F. Günthard, A. Oxenius, P. Meylan, and et al. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection J. Virol. 78 2004 10747 10754
9. M. Crispin, and K.J. Doores Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design Curr. Opin. Virol. 11 2015 63 69
10. M.D. Daugherty, and H.S. Malik Rules of engagement: molecular insights from host-virus arms races Annu. Rev. Genet. 46 2012 677 700
11. T. Doyle, C. Goujon, and M.H. Malim HIV-1 and interferons: who's interfering with whom? Nat. Rev. Microbiol. 13 2015 403 413
12. R.A. Fouchier, M. Brouwer, N.A. Kootstra, H.G. Huisman, and H. Schuitemaker HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle J. Clin. Invest. 94 1994 1806 1814
13. H.E. Gendelman, J.M. Orenstein, M.A. Martin, C. Ferrua, R. Mitra, T. Phipps, L.A. Wahl, H.C. Lane, A.S. Fauci, D.S. Burke, and et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes J. Exp. Med. 167 1988 1428 1441
14. C. Goujon, O. Moncorgé, H. Bauby, T. Doyle, C.C. Ward, T. Schaller, S. Hué, W.S. Barclay, R. Schulz, and M.H. Malim Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection Nature 502 2013 559 562
15. S. Guerrero, J. Batisse, C. Libre, S. Bernacchi, R. Marquet, and J.C. Paillart HIV-1 replication and the cellular eukaryotic translation apparatus Viruses 7 2015 199 218
16. R.S. Harris, J.F. Hultquist, and D.T. Evans The restriction factors of human immunodeficiency virus J. Biol. Chem. 287 2012 40875 40883
17. Y. Itsui, N. Sakamoto, S. Kakinuma, M. Nakagawa, Y. Sekine-Osajima, M. Tasaka-Fujita, Y. Nishimura-Sakurai, G. Suda, Y. Karakama, K. Mishima, and et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein Hepatology 50 2009 1727 1737
18. M. Kane, S.S. Yadav, J. Bitzegeio, S.B. Kutluay, T. Zang, S.J. Wilson, J.W. Schoggins, C.M. Rice, M. Yamashita, T. Hatziioannou, and P.D. Bieniasz MX2 is an interferon-induced inhibitor of HIV-1 infection Nature 502 2013 563 566
19. B.-H. Kim, A.R. Shenoy, P. Kumar, C.J. Bradfield, and J.D. MacMicking IFN-inducible GTPases in host cell defense Cell Host Microbe 12 2012 432 444
20. F. Kirchhoff Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses Cell Host Microbe 8 2010 55 67
21. S.F. Kluge, D. Sauter, and F. Kirchhoff SnapShot: antiviral restriction factors Cell 163 2015 10.1016/j.cell.2015.10.019
22. A. Krupp, K.R. McCarthy, M. Ooms, M. Letko, J.S. Morgan, V. Simon, and W.E. Johnson APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host PLoS Pathog. 9 2013 e1003641
23. Y. Li, J.C. Kappes, J.A. Conway, R.W. Price, G.M. Shaw, and B.H. Hahn Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes J. Virol. 65 1991 3973 3985
24. S. Martens, and J. Howard The interferon-inducible GTPases Annu. Rev. Cell Dev. Biol. 22 2006 559 589
25. K.A. Matreyek, W. Wang, E. Serrao, P.K. Singh, H.L. Levin, and A. Engelman Host and viral determinants for MxB restriction of HIV-1 infection Retrovirology 11 2014 90
26. P.J. McLaren, A. Gawanbacht, N. Pyndiah, C. Krapp, D. Hotter, S.F. Kluge, N. Götz, J. Heilmann, K. Mack, D. Sauter, and et al. Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses Retrovirology 12 2015 41
27. N. Modiano, Y.E. Lu, and P. Cresswell Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor Proc. Natl. Acad. Sci. USA 102 2005 8680 8685
28. H.M. Naif, S. Li, M. Alali, J. Chang, C. Mayne, J. Sullivan, and A.L. Cunningham Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins J. Virol. 73 1999 4866 4881
29. S.J.D. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430
30. W. Pan, X. Zuo, T. Feng, X. Shi, and J. Dai Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus Virol. J. 9 2012 292
31. N.F. Parrish, F. Gao, H. Li, E.E. Giorgi, H.J. Barbian, E.H. Parrish, L. Zajic, S.S. Iyer, J.M. Decker, A. Kumar, and et al. Phenotypic properties of transmitted founder HIV-1 Proc. Natl. Acad. Sci. USA 110 2013 6626 6633
32. N. Pawlowski, A. Khaminets, J.P. Hunn, N. Papic, A. Schmidt, R.C. Uthaiah, R. Lange, G. Vopper, S. Martens, E. Wolf, and J.C. Howard The activation mechanism of Irga6, an interferon-inducible GTPase contributing to mouse resistance against Toxoplasma gondii BMC Biol. 9 2011 7
33. E. Pesenti, C. Pastore, F. Lillo, A.G. Siccardi, D. Vercelli, and L. Lopalco Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates AIDS Res. Hum. Retroviruses 15 1999 983 987
34. G.J.K. Praefcke, S. Kloep, U. Benscheid, H. Lilie, B. Prakash, and C. Herrmann Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis J. Mol. Biol. 344 2004 257 269
35. M. Rotger, K.K. Dang, J. Fellay, E.L. Heinzen, S. Feng, P. Descombes, K.V. Shianna, D. Ge, H.F. Günthard, D.B. Goldstein, A. Telenti Swiss HIV Cohort Study Center for HIV/AIDS Vaccine Immunology Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals PLoS Pathog. 6 2010 e1000781
36. D. Sauter, D. Hotter, B. Van Driessche, C.M. Stürzel, S.F. Kluge, S. Wildum, H. Yu, B. Baumann, T. Wirth, J.-C. Plantier, and et al. Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins Cell Rep. 10 2015 586 599
37. M. Schindler, J. Münch, O. Kutsch, H. Li, M.L. Santiago, F. Bibollet-Ruche, M.C. Müller-Trutwin, F.J. Novembre, M. Peeters, V. Courgnaud, and et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1 Cell 125 2006 1055 1067
38. M. Schindler, D. Rajan, C. Banning, P. Wimmer, H. Koppensteiner, A. Iwanski, A. Specht, D. Sauter, T. Dobner, and F. Kirchhoff Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue Retrovirology 7 2010 1
39. J.L. Schmid-Burgk, T. Schmidt, M.M. Gaidt, K. Pelka, E. Latz, T.S. Ebert, and V. Hornung OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines Genome Res. 24 2014 1719 1723
40. T. Schmidt, J.L. Schmid-Burgk, and V. Hornung Synthesis of an arrayed sgRNA library targeting the human genome Sci. Rep. 5 2015 14987
41. T. Schmidt, J.L. Schmid-Burgk, T.S. Ebert, M.M. Gaidt, and V. Hornung Designer Nuclease-Mediated Generation of Knockout THP1 Cells Methods Mol. Biol. 1338 2016 261 272
42. G. Schnell, S. Spudich, P. Harrington, R.W. Price, and R. Swanstrom Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia PLoS Pathog. 5 2009 e1000395
43. U. Schubert, S. Bour, R.L. Willey, and K. Strebel Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env J. Virol. 73 1999 887 896
44. S. Schwartz, B.K. Felber, E.M. Fenyö, and G.N. Pavlakis Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs J. Virol. 64 1990 5448 5456
45. A.R. Shenoy, D.A. Wellington, P. Kumar, H. Kassa, C.J. Booth, P. Cresswell, and J.D. MacMicking GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals Science 336 2012 481 485
46. T.S. Theodore, G. Englund, A. Buckler-White, C.E. Buckler, M.A. Martin, and K.W. Peden Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions AIDS Res. Hum. Retroviruses 12 1996 191 194
47. E.R. Thomas, R.L. Dunfee, J. Stanton, D. Bogdan, K. Kunstman, S.M. Wolinsky, and D. Gabuzda High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia AIDS Res. Hum. Retroviruses 23 2007 575 580
48. N. Van Damme, D. Goff, C. Katsura, R.L. Jorgenson, R. Mitchell, M.C. Johnson, E.B. Stephens, and J. Guatelli The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein Cell Host Microbe 3 2008 245 252
49. A.M. Waterhouse, J.B. Procter, D.M.A. Martin, M. Clamp, and G.J. Barton Jalview Version 2 - a multiple sequence alignment editor and analysis workbench Bioinformatics 25 2009 1189 1191
50. M. Wehner, and C. Herrmann Biochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variant FEBS J. 277 2010 1597 1605
51. R.L. Willey, F. Maldarelli, M.A. Martin, and K. Strebel Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 J. Virol. 66 1992 7193 7200